Published in

SAGE Publications, Genes and Cancer, 4(2), p. 485-490

DOI: 10.1177/1947601911409745

Links

Tools

Export citation

Search in Google Scholar

TP53-Associated Pediatric Malignancies

Journal article published in 2011 by Emilia M. Pinto ORCID, Raul C. Ribeiro, Bonald C. Figueiredo ORCID, Gerard P. Zambetti
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Although the majority of pediatric malignancies express wild-type p53, it is well established that germline TP53 mutations or functional inactivation of this pathway by other means contribute to childhood cancer. Epidemiology studies have revealed the existence of diverse inherited mutant TP53 alleles that display different levels of tumor suppressor activity, which correlate with cancer risk in terms of penetrance, age of onset, and tumor types. In this monograph, the authors describe those childhood cancers associated with functional inactivation of TP53 focusing on adrenocortical carcinoma as a model for tissues that are highly sensitive to loss of p53 activity.